Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. [electronic resource]
Producer: 20030911Description: 791-8 p. digitalISSN:- 0149-5992
- Aged
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Glucagon -- administration & dosage
- Glucagon-Like Peptide 1
- Humans
- Infusions, Intravenous
- Insulin -- metabolism
- Insulin Secretion
- Islets of Langerhans -- drug effects
- Male
- Middle Aged
- Peptide Fragments -- administration & dosage
- Protein Precursors -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.